The Bailing Capsule, as a major C. sinensis preparation, its pharmacological mechanism in treating CKD may be related to immune response and inflammatory response (14), but there are also studies that find The Bailing Capsule can achieve the same effect of treating CKD by regulating the PPARα pathway (19). The gene discussed is PPARA; the disease is chronic kidney disease.